4.4 Article

Low-dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients

Related references

Note: Only part of the references are listed.
Article Health Care Sciences & Services

Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study

Magali Courade et al.

Summary: Low doses of ketamine added to opioids significantly reduced the intensity of pain and showed potential opioid-sparing effects in pediatric and adolescent patients with cancer.

BMJ SUPPORTIVE & PALLIATIVE CARE (2022)

Article Oncology

Multimodal Analgesic Plan for Children Undergoing Chimeric 14.18 Immunotherapy

Gianluca Bertolizio et al.

Summary: A multimodal regimen based on gabapentin, ketamine, and morphine was effective in controlling neuropathic pain associated with ch14.18 antibody immunotherapy, with low levels of pain and infrequent occurrence of side effects such as desaturation and hypotension. This regimen may be a viable analgesic option for children undergoing ch14.18 infusion.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2021)

Review Oncology

A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease

Emily M. Harris et al.

Summary: Ketamine is shown to be a safe and effective treatment for VOE pain, but standardized infusion protocols are needed due to significant variability in clinical studies. Further research and exploration are warranted to establish consistent guidelines for managing VOE pain effectively.

PEDIATRIC BLOOD & CANCER (2021)

Review Emergency Medicine

Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises

Jonathan M. Hagedorn et al.

PEDIATRIC EMERGENCY CARE (2019)

Article Anesthesiology

Subanesthetic ketamine infusions for the management of pediatric pain in non-critical care settings: An observational analysis

Melissa M. Masaracchia et al.

ACTA ANAESTHESIOLOGICA SCANDINAVICA (2019)

Review Health Care Sciences & Services

Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease

Latika Puri et al.

CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2019)

Review Anesthesiology

Pain measurement and critical review of analgesic trials pain scores, functional pain measurements, limits and bias of clinical trials

Adrien Lemoine et al.

BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2019)

Article Clinical Neurology

Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial

Felix Anthony Lubega et al.

SCANDINAVIAN JOURNAL OF PAIN (2018)

Editorial Material Health Care Sciences & Services

Continuous Intravenous Infusion of Ketamine and Lidocaine as Adjuvant Analgesics in a 5-Year-Old Patient with Neuropathic Cancer Pain

Teruyuki Kajiume et al.

JOURNAL OF PALLIATIVE MEDICINE (2012)

Review Anesthesiology

A systematic review of intravenous ketamine for postoperative analgesia

Kevin Laskowski et al.

CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2011)

Article Anesthesiology

Effects of perioperative intravenous low dose of ketamine on postoperative analgesia in children

Veronique Bazin et al.

EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2010)

Editorial Material Pharmacology & Pharmacy

Ketamine for the treatment of chronic non-cancer pain

Ingeborg Noppers et al.

EXPERT OPINION ON PHARMACOTHERAPY (2010)

Article Oncology

Use of Continuous Intravenous Ketamine for End-Stage Cancer Pain in Children

Mary Conway et al.

JOURNAL OF PEDIATRIC ONCOLOGY NURSING (2009)

Editorial Material Pediatrics

What is the evidence for the safety and efficacy of using ketamine in children?

G. Dolansky et al.

PAEDIATRICS & CHILD HEALTH (2008)

Article Clinical Neurology

Ketamine as an adjuvant for treatment of cancer pain in children and adolescents

Julia C. Finkel et al.

JOURNAL OF PAIN (2007)